Search by Drug Name or NDC
NDC 00006-4096-02 VAQTA 50 [iU]/mL Details
VAQTA 50 [iU]/mL
VAQTA is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED).
MedlinePlus Drug Summary
Why get vaccinated against hepatitis A? Hepatitis A vaccine can prevent hepatitis A. Hepatitis A is a serious liver disease. It is usually spread through close, personal contact with an infected person or when a person unknowingly ingests the virus from objects, food, or drinks that are contaminated by small amounts of stool (poop) from an infected person. Most adults with hepatitis A have symptoms, including fatigue, low appetite, stomach pain, nausea, and jaundice (yellow skin or eyes, dark urine, light-colored bowel movements). Most children less than 6 years of age do not have symptoms. A person infected with hepatitis A can transmit the disease to other people even if he or she does not have any symptoms of the disease. Most people who get hepatitis A feel sick for several weeks, but they usually recover completely and do not have lasting liver damage. In rare cases, hepatitis A can cause liver failure and death; this is more common in people older than 50 years and in people with other liver diseases. Hepatitis A vaccine has made this disease much less common in the United States. However, outbreaks of hepatitis A among unvaccinated people still happen.
Related Packages: 00006-4096-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Hepatitis A Vaccine
Product Information
NDC | 00006-4096 |
---|---|
Product ID | 0006-4096_261399ed-0541-4663-84c7-fef1bcd0bcf4 |
Associated GPIs | 17100008001870 |
GCN Sequence Number | 062812 |
GCN Sequence Number Description | hepatitis A virus vaccine/PF SYRINGE 50 UNIT/ML INTRAMUSC |
HIC3 | W7B |
HIC3 Description | VIRAL/TUMORIGENIC VACCINES |
GCN | 98583 |
HICL Sequence Number | 034417 |
HICL Sequence Number Description | HEPATITIS A VIRUS VACCINE/PF |
Brand/Generic | Brand |
Proprietary Name | VAQTA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | hepatitis A vaccine, inactivated |
Product Type | VACCINE |
Dosage Form | INJECTION, SUSPENSION |
Route | INTRAMUSCULAR |
Active Ingredient Strength | 50 |
Active Ingredient Units | [iU]/mL |
Substance Name | HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) |
Labeler Name | Merck Sharp & Dohme LLC |
Pharmaceutical Class | Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA103606 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00006-4096-02 (00006409602)
NDC Package Code | 0006-4096-02 |
---|---|
Billing NDC | 00006409602 |
Package | 10 SYRINGE in 1 CARTON (0006-4096-02) / 1 mL in 1 SYRINGE (0006-4096-01) |
Marketing Start Date | 1996-03-29 |
NDC Exclude Flag | N |
Pricing Information | N/A |